Novavax: Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot.

Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot. · Barrons.com In This Article: Novavax stock was up on Monday amid roiling uncertainty about its Covid-19 vaccine approval, which has been caught up in the turbid health politics of the second Trump administration. Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 vaccine after it grants the shot full approval, saying the request for a post-approval trial was "not unusual." "Using the COVID pandemic as an eternal justification for blanket approvals of new products will not happen under the leadership of Commissioner Makary," the official told Barron's.